ORAL FLUID TESTING ABUSE OF DRUGS FOR HOME USE
ID: 36C24525Q0374Type: Special Notice
Overview

Buyer

VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OF245-NETWORK CONTRACT OFFICE 5 (36C245)LINTHICUM, MD, 21090, USA

NAICS

Surgical and Medical Instrument Manufacturing (339112)

PSC

MEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES (6515)

Original Source

https://sam.gov/opp/34847adfd9444f1bac7e21bca0434ec2/view
Timeline
    Description

    The Department of Veterans Affairs is seeking information regarding an oral fluid testing solution for at-home use by patients enrolled in Substance Use Disorder (SUD) programs via telehealth. The procurement aims to identify a device that has FDA clearance, can provide results within 5 to 15 minutes, and tests for substances such as methamphetamine, cocaine, amphetamine, and THC, with results viewable during virtual appointments. This initiative is crucial for facilitating timely interventions in SUD treatment through evidence-based contingency management strategies. Interested manufacturers should respond with their capabilities and technologies, and can contact Alison Klein at ALISON.KLEIN@VA.GOV or by phone at 304-623-3461 for further information.

    Point(s) of Contact
    ALISON KLEIN
    30462334614143
    ALISON.KLEIN@VA.GOV
    Files
    Title
    Posted
    36C24525Q0374_1.docx
    The Department of Veterans Affairs (VA) is seeking information for a new oral fluid drug testing solution suitable for at-home use by patients enrolled in Substance Use Disorder (SUD) programs via telehealth. The proposed device must have FDA clearance, allowing it to be used without prescriptions and capable of providing results within 5 to 15 minutes. Key requirements include tests for methamphetamine, cocaine, amphetamine, and THC, with accurate results viewable during virtual appointments. Clinical training and comprehensive documentation are mandated for effective utilization. Additionally, respondents are expected to provide details on device performance and ensure a one-year warranty post-acceptance. This Request for Information (RFI) aims to support the development of a reliable and integrated drug testing system that facilitates timely intervention in SUD treatment, aligning with evidence-based contingency management strategies. The RFI is not a solicitation but serves as a planning tool, inviting manufacturers to respond with relevant capabilities and technologies.
    Lifecycle
    Title
    Type
    ORAL FLUID TESTING ABUSE OF DRUGS FOR HOME USE
    Currently viewing
    Special Notice
    Similar Opportunities
    6505--36C77026Q0061/RFI/Domestic Sources Rx_MedSurge
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is seeking information from domestic pharmaceutical manufacturers through a Request for Information (RFI) designated 36C77026Q0061, aimed at supporting the Consolidated Mail Outpatient Pharmacy (CMOP) in fulfilling its Open Market (OM) purchasing needs. The RFI seeks to identify both small and large businesses capable of providing a range of pharmaceutical products and ancillary items, with a focus on those manufactured in the United States, to enhance the supply chain for approximately 450,000 prescriptions mailed daily to Veterans. Interested manufacturers are required to submit detailed company and product information, including FDA-approved NDC numbers and operational capabilities, by March 15, 2026, at 4:30 PM CT. For further inquiries, respondents can contact Michael McAlhaney at Michael.McAlhaney@va.gov or (913) 684-1976.
    6505--Nicotine Lozenges MINI (VA-26-00020754)
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is preparing to issue a Request for Proposal (RFP) for the procurement of Nicotine Mini Lozenges, specifically under solicitation number 36E79726R0007. This contract aims to ensure an uninterrupted supply of nicotine lozenges for the VA, Department of Defense (DOD), Bureau of Prisons (BOP), and Indian Health Service (IHS), with a contract duration of one year and four optional one-year extensions. The estimated annual requirements include 166,791 bottles of 2mg lozenges and 138,276 bottles of 4mg lozenges, which will be distributed through the VA and DOD Pharmaceutical Prime Vendor Programs. Interested offerors should note that the solicitation will be electronically issued around December 18, 2025, with a tentative closing date of January 1, 2026, and can direct inquiries to Billy Fong at billy.fong@va.gov or by phone at 708-786-4992.
    DA01--State Prescription Drug Monitoring Program (PDMP) Integration Solution and Support Services - New Task Order (VA-26-00013141)
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is seeking qualified vendors to provide integration solutions and sustainment support services for its State Prescription Drug Monitoring Program (PDMP) under task order VA-26-00013141. The procurement aims to maintain and enhance the existing PDMP solution, which connects VA healthcare providers to a national network of state-based PDMPs, facilitating the querying of controlled substance prescriptions. This initiative is crucial for improving patient safety and ensuring compliance with the MISSION Act Section 134. Interested vendors, particularly Service-Disabled Veteran-Owned Small Businesses (SDVOSBs) and Veteran-Owned Small Businesses (VOSBs) certified by the SBA's VetCert program, must submit their responses by January 5, 2026, at 10 AM EST, detailing their technical capabilities and experience, with a focus on the requirements outlined in the attached Request for Information documents. For further inquiries, contact Contract Specialist Edward Olivo-Cruz at Edward.Olivo-Cruz@va.gov or 848-377-5099.
    COLESTIPOL HCL 1GM TAB and DESONIDE 0.05% CREAM - 762 TUCSON
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is conducting a Sources Sought Notice to identify potential qualified domestic sources for the procurement of COLESTIPOL HCL 1GM TAB and DESONIDE 0.05% CREAM through its National CMOP Office. This announcement serves as a market research tool rather than a solicitation, aiming to gather information on vendors' capabilities to meet the requirements outlined in the Statement of Requirements. The products sought are critical for pharmaceutical preparation and will support the healthcare needs of veterans. Interested vendors must submit their responses, including company details and capability statements, via email to Jennifer Coleman at Jennifer.Coleman4@va.gov by December 19, 2025, at 3:00 PM CDT. This notice does not obligate the VA to issue a solicitation.
    6520--635 New Dental Water Testing Oklahoma City VAMC
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is seeking a qualified contractor to provide mail-order testing kits and laboratory analysis of dental unit waterline samples for the Oklahoma City VA Medical Center. The contractor will be responsible for testing for colony forming units (CFU) in accordance with VA Infection Control Standards, ensuring that services are delivered in a cost-effective, safe, efficient, and secure manner. This contract is crucial for maintaining the health and safety standards within VA Dental Clinics, emphasizing the importance of compliance with infection control protocols. Interested contractors should contact Contract Specialist Orrellius Williams at orrellius.williams@va.gov or call 918-252-8812 for further details, and must be prepared to commence services within five business days of a task order.
    U099--SOURCES SOUGHT: Test2Learn Education (PGx)
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is seeking information from potential contractors for Pharmacogenomics (PGx) Education and Training Services through a Sources Sought Notice. The objective is to enhance PGx expertise among clinicians, including pharmacists, advanced practice providers, nurses, and pharmacy technicians, to improve personalized patient care and medication safety. The contractor will be responsible for delivering accredited multimodal education, including both asynchronous and synchronous courses, with a goal of certifying at least 1,000 participants annually. The contract will be structured as a firm-fixed-price agreement with a 12-month base period and two 12-month option periods, requiring compliance with Section 508 accessibility standards. Interested parties can contact Contracting Officer Wanda Y. Edwards at Wanda.Edwards@va.gov or by phone at 240-215-1642 for further information.
    Home Sleep Apnea Testing
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking proposals for Home Sleep Apnea Testing (HSAT) services for veterans at the John J. Pershing VA Medical Center in Poplar Bluff, Missouri, and its associated Community Based Outpatient Clinics. The procurement involves providing HSAT equipment, technical support, and scoring reports, with a focus on ensuring compatibility with existing Somnoware software, which is essential for effective patient care and data management. This contract, valued at an estimated $20.5 million, will be awarded as an Indefinite Delivery Indefinite Quantity (IDIQ) Firm-Fixed Price (FFP) contract, covering a base period and four option years from May 1, 2026, to April 30, 2031. Interested parties can contact Denise Maynard at denise.maynard@va.gov or by phone at 913-946-1116 for further information.
    6640--Request For Information (RFI)-Molecular Diagnostic Testing for Fort Harrison VA Medical Center (Fort Harrison, MT) and Benjamin Steele VA Clinic (Billings, MT)
    Veterans Affairs, Department Of
    The Department of Veterans Affairs, through the Network Contracting Office 19, is seeking information from vendors capable of providing Polymerase Chain Reaction (PCR) Molecular Diagnostic Cost Per Test (CPT) services for the Fort Harrison VA Medical Center and Benjamin Steele VA Clinic in Montana. The procurement requires vendors to supply two analyzers that can perform specific molecular diagnostic tests, including respiratory pathogen panels and blood culture identification, while ensuring minimal hands-on time for medical technologists. This initiative is crucial for enhancing the accuracy and efficiency of molecular virology results in veteran healthcare. Interested parties must submit their capability statements, including business size status, to Contract Specialist Ernest Appiah via email by January 5, 2026, at 9 AM Mountain Time.
    To Correct Description
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking responses to a Special Notice regarding a procurement opportunity related to medical laboratory testing services. Respondents are required to complete specific columns in the attached test list, particularly Columns D and E, which pertain to in-house testing capabilities and third-party courier services. This opportunity is crucial for ensuring the availability and accuracy of medical laboratory tests, which play a vital role in patient care and treatment decisions. Interested parties should reach out to Eric A. Lingenfelter at Eric.Lingenfelter@va.gov or call 360-852-9891 for further details and to obtain the necessary documents for submission.
    6515--Clitoral Therapy Device (CTD) (VA-24-00037945)
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is soliciting proposals for the procurement of Clitoral Therapy Devices (CTD) and associated accessories under solicitation number 36C10G26Q0004. The objective of this procurement is to standardize products and reduce costs within the Veterans Health Administration (VHA), requiring FDA-approved devices that meet specific technical specifications, including removable cups, extension tubing, and a one-year warranty. These devices are critical for providing therapeutic support to veterans, ensuring they receive necessary medical care. Interested vendors should contact Contract Specialist Jessica L. Abrams at Jessica.Abrams@va.gov for further details, with proposals due by the specified deadline. The contract will be structured as an indefinite-quantity contract with a one-year base period and four one-year options, and contractors will be required to submit quarterly sales reports and pay a Service Level Agreement (SLA) fee.